ストックスクリーナーアプリを入手
46.72
4.03%
-2.00
前日終値:
$48.72
開ける：
$47.63
24時間の取引高:
177.07K
Relative Volume:
0.12
時価総額：
$3.31B
収益：
-
当期純損益:
$-218.28M
株価収益率:
-13.05
EPS:
-3.5803
ネットキャッシュフロー:
$-186.55M
1週間 パフォーマンス:
+0.52%
1か月 パフォーマンス:
-13.27%
6か月 パフォーマンス:
+106.60%
1年 パフォーマンス:
+37.15%
1日の値動き範囲:
$46.62
$48.64
1週間の範囲:
$44.55
$49.33
52週間の値動き範囲:
$18.53
$56.05
Vera Therapeutics Inc Stock (VERA) Company Profile
名前
Vera Therapeutics Inc
セクター
電話
650-770-0077
住所
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
46.69 | 3.46B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.74 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.29 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
813.59 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.61 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.72 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-16 | 開始されました | BofA Securities | Buy |
| 2025-08-04 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2025-01-28 | 開始されました | Goldman | Buy |
| 2024-11-21 | 開始されました | Wells Fargo | Overweight |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-01-25 | 開始されました | Oppenheimer | Outperform |
| 2024-01-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 開始されました | Raymond James | Outperform |
| 2023-11-10 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-16 | 開始されました | Guggenheim | Buy |
| 2023-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-04 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-07-12 | 開始されました | JP Morgan | Overweight |
| 2022-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2022-04-19 | 開始されました | Wedbush | Outperform |
すべてを表示
Vera Therapeutics Inc (VERA) 最新ニュース
SG Americas Securities LLC Takes $911,000 Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Buyout Rumor: Is Vera Therapeutics Inc vulnerable to short sellersWeekly Investment Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Insider Buy: Whats the analyst consensus on Vera Therapeutics IncTake Profit & Safe Capital Investment Plans - baoquankhu1.vn
Cantor Fitzgerald reiterates Overweight rating on Vera Therapeutics stock By Investing.com - Investing.com Canada
Published on: 2026-01-16 22:59:19 - baoquankhu1.vn
Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept - Insider Monkey
14 Best Booming Stocks to Buy Right Now - Insider Monkey
Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High? - sharewise.com
Understanding the Setup: (VERA) and Scalable Risk - Stock Traders Daily
Vera Therapeutics, Inc. (VERA) Stock Analysis: A 62% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Vera Therapeutics (NASDAQ:VERA) Shares Down 7.4%Here's Why - MarketBeat
Assessing Vera Therapeutics (VERA) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Short report: Vera Therapeutics bears retreat as stock rallies - MSN
Does FDA Priority Review For Atacicept Reshape The Bull Case For Vera Therapeutics (VERA)? - Yahoo Finance
Will Vera Therapeutics Inc. stock split again soonJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - Улправда
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Why Vera Therapeutics (VERA) Is Down 5.8% After FDA Priority Review Acceptance For AtaciceptAnd What's Next - Sahm
What risks investors should watch in Vera Therapeutics Inc. stockCEO Change & Free Expert Verified Stock Movement Alerts - Улправда
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Sahm
A Look At Vera Therapeutics (VERA) Valuation After FDA Priority Review For Atacicept In IgA Nephropathy - Sahm
Is Vera Therapeutics Inc. stock gaining market share2025 Growth vs Value & AI Powered Market Entry Ideas - Улправда
Upcoming EventsVera Therapeutics, Inc.Class A Common Stock (Nasdaq:VERA) Detailed Stock Data - FinancialContent
Vera Therapeutics, Inc.'s (NASDAQ:VERA) Shift From Loss To Profit - 富途牛牛
Will Vera Therapeutics Inc. stock attract ESG investorsRisk Management & AI Powered Market Entry Ideas - ulpravda.ru
Is Vera Therapeutics Inc. stock a safe buy before earningsJuly 2025 Reactions & Community Driven Trade Alerts - ulpravda.ru
Los Angeles Daily NewsVera Therapeutics, Inc.Class A Common Stock (Nasdaq:VERA) Stock Quote - FinancialContent
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ - openPR.com
Why Vera Therapeutics Stock Zoomed Higher Today - The Globe and Mail
FDA Fast-Tracks Vera's At-Home Kidney Drug - Benzinga
Vera Therapeutics stock rises after FDA accepts atacicept BLA with Priority Review - Investing.com Nigeria
Vera Therapeutics stock rises after FDA accepts atacicept BLA with Priority Review By Investing.com - Investing.com South Africa
Vera Therapeutics shares up 3% after co receives U.S. FDA priority review for kidney disease drug - marketscreener.com
Vera Therapeutics' Atacicept Receives FDA Priority Review for Treatment of IgAN with PDUFA Date Set for July 7, 2026 - Quiver Quantitative
Vera Therapeutics Announces U.S. FDA Granted Priority - GlobeNewswire
Vera Therapeutics Announces U.S. FDA Granted Priority Review To Biologics License Application - TradingView — Track All Markets
FDA Expedites Approval of Vera’s Home-Based Kidney Medication - Bitget
Wells Fargo sees short squeeze ahead: here are three stocks to play it - CryptoRank
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Vera started at buy by Goldman Sachs, atacicept potential cited - MSN
These Bay Area drugmakers are hurtling toward key FDA approval decisions in 2026 - The Business Journals
Quarterly Earnings: Will Vera Therapeutics Inc stock attract ESG investors2025 Market Trends & Accurate Technical Buy Alerts - moha.gov.vn
Stock Traders Purchase Large Volume of Vera Therapeutics Call Options (NASDAQ:VERA) - MarketBeat
Vera Therapeutics stock drops 3% today as biotech slips into year-end trading - ts2.tech
Vera Therapeutics announces $200M public offering - MSN
Entry Recap: What risks investors should watch in Vera Therapeutics Inc stockJuly 2025 Momentum & Consistent Return Investment Signals - moha.gov.vn
Vera Therapeutics price target raised to $33 from $23 at Wedbush - MSN
50,000 Shares in Vera Therapeutics, Inc. $VERA Purchased by Swedbank AB - MarketBeat
Vera Therapeutics Inc (VERA) 財務データ
収益
当期純利益
現金流量
EPS
4.38%
1.95%
大文字化:
|
ボリューム (24 時間):